As part of a broad initiative to prepare for and prevent future global disease outbreaks, White House officials recently announced a nearly $3 billion program to ramp up production of vaccines and their components to better serve patients in the United States and globally. This program is part of a broader $65 billion, 10-year pandemic preparedness plan announced Sept. 3, 2021 that also supports development of new therapeutics and diagnostics, as well as improved infectious disease surveillance, expansion of the national stockpile of critical medical supplies, and building regulatory oversight of these programs see “American Pandemic Plan: Transforming Our Capabilities”.
